iEntry 10th Anniversary
RSS
Newsletter
Advertising
According to a post on over on InsideGoogle, "Celebrex Soars, At Least In Ad Dollars", we learn that ...
"Celebrex, the keyword, has soared, as personal injury attorneys scramble to buy the keyword for big bucks at Overture and AdWords, MarketWatch is reporting. The Overture cost of Celebrex soared from 95 cents on Friday to $4.02 today, following news that the FDA was considering regulatory measures for the best-selling arthritis drug."
Celebrex the arthritis drug?
Wow!
I never really thought about how FDA action against particular drugs would affect keyword ad buys. Sure, I've seen how it affects the stock prices of drug companies, but this is a bit unexpected.
It's a brave new world, with new economies that are ripe for study.
Jeremy Zawodny is the author of the popular Jeremy Zawodny's blog. Jeremy is part of the Yahoo search team and frequently posts in the Yahoo! Search blog as well.
Visit Jeremy's blog: Jeremy Zawodny's blog.
Publish A Comment
-
What Makes a Quality URL?
In setting up a website, the URL is one of the most important... -
Getting Noticed with Google Maps
Are you utilizing Google Maps? If not, you could be hurting your... -
Gray Areas of FTC Guidelines
Although the FTC's new advertising guidelines are scheduled to go...
     |